Jill Patton, MD | |
1971 Western Ave # 257, Albany, NY 12203-5066 | |
(518) 227-1887 | |
Not Available |
Full Name | Jill Patton |
---|---|
Gender | Female |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 1971 Western Ave # 257, Albany, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831333251 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 16286 (New Hampshire) | Secondary |
2084P0800X | Psychiatry & Neurology - Psychiatry | 282440 (New York) | Primary |
Entity Name | Hospitalist Healthcare Services Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275962011 PECOS PAC ID: 1557599313 Enrollment ID: O20140124001195 |
News Archive
Researchers funded in part by the National Institute of Biomedical Imaging and Bioengineering have recently shown that magnetic bacteria are a promising vehicle for more efficiently delivering tumor-fighting drugs. They reported their results in the August 2016 issue of Nature Nanotechnology.
Nektar Therapeutics today announced that new Phase 2 clinical data for NKTR-102, Nektar's lead oncology candidate being evaluated in multiple cancer indications, have been selected for presentation at the 47th Annual Meeting of the American Society of Clinical Oncology being held June 3-7, 2011 in Chicago, Illinois.
How is individualized medicine working? Let us count the ways. That's just what Mayo Clinic Vice President Gianrico Farrugia, M.D., did this morning in his opening keynote at the 4th annual Individualizing Medicine Conference. The core of his talk highlighted five areas in which the knowledge and know-how from the human genome will be most impactful in patient care, not just at Mayo Clinic, but anywhere in the nation and globally.
Tumors are not a uniform mass of cells. Colon cancers bear differentiated-like cells, similar to the functional cells of the intestinal wall, and pluripotent cells-the so-called tumour stem cells.
Researchers in Australia are developing diversionary tactics to fool disease-causing bacteria in the gut. Many bacteria, including those responsible for major gut infections, such as cholera, produce toxins that damage human tissues when they bind to complex sugar receptors displayed on the surface of cells in the host's intestine.
› Verified 8 days ago
Entity Name | New York General Medical Services Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700315538 PECOS PAC ID: 7810255494 Enrollment ID: O20180103003151 |
News Archive
Researchers funded in part by the National Institute of Biomedical Imaging and Bioengineering have recently shown that magnetic bacteria are a promising vehicle for more efficiently delivering tumor-fighting drugs. They reported their results in the August 2016 issue of Nature Nanotechnology.
Nektar Therapeutics today announced that new Phase 2 clinical data for NKTR-102, Nektar's lead oncology candidate being evaluated in multiple cancer indications, have been selected for presentation at the 47th Annual Meeting of the American Society of Clinical Oncology being held June 3-7, 2011 in Chicago, Illinois.
How is individualized medicine working? Let us count the ways. That's just what Mayo Clinic Vice President Gianrico Farrugia, M.D., did this morning in his opening keynote at the 4th annual Individualizing Medicine Conference. The core of his talk highlighted five areas in which the knowledge and know-how from the human genome will be most impactful in patient care, not just at Mayo Clinic, but anywhere in the nation and globally.
Tumors are not a uniform mass of cells. Colon cancers bear differentiated-like cells, similar to the functional cells of the intestinal wall, and pluripotent cells-the so-called tumour stem cells.
Researchers in Australia are developing diversionary tactics to fool disease-causing bacteria in the gut. Many bacteria, including those responsible for major gut infections, such as cholera, produce toxins that damage human tissues when they bind to complex sugar receptors displayed on the surface of cells in the host's intestine.
› Verified 8 days ago
Entity Name | Mikram Jafri Md Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831800747 PECOS PAC ID: 1052783396 Enrollment ID: O20230214001494 |
News Archive
Researchers funded in part by the National Institute of Biomedical Imaging and Bioengineering have recently shown that magnetic bacteria are a promising vehicle for more efficiently delivering tumor-fighting drugs. They reported their results in the August 2016 issue of Nature Nanotechnology.
Nektar Therapeutics today announced that new Phase 2 clinical data for NKTR-102, Nektar's lead oncology candidate being evaluated in multiple cancer indications, have been selected for presentation at the 47th Annual Meeting of the American Society of Clinical Oncology being held June 3-7, 2011 in Chicago, Illinois.
How is individualized medicine working? Let us count the ways. That's just what Mayo Clinic Vice President Gianrico Farrugia, M.D., did this morning in his opening keynote at the 4th annual Individualizing Medicine Conference. The core of his talk highlighted five areas in which the knowledge and know-how from the human genome will be most impactful in patient care, not just at Mayo Clinic, but anywhere in the nation and globally.
Tumors are not a uniform mass of cells. Colon cancers bear differentiated-like cells, similar to the functional cells of the intestinal wall, and pluripotent cells-the so-called tumour stem cells.
Researchers in Australia are developing diversionary tactics to fool disease-causing bacteria in the gut. Many bacteria, including those responsible for major gut infections, such as cholera, produce toxins that damage human tissues when they bind to complex sugar receptors displayed on the surface of cells in the host's intestine.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Jill Patton, MD 1971 Western Ave # 257, Albany, NY 12203-5066 Ph: (518) 227-1887 | Jill Patton, MD 1971 Western Ave # 257, Albany, NY 12203-5066 Ph: (518) 227-1887 |
News Archive
Researchers funded in part by the National Institute of Biomedical Imaging and Bioengineering have recently shown that magnetic bacteria are a promising vehicle for more efficiently delivering tumor-fighting drugs. They reported their results in the August 2016 issue of Nature Nanotechnology.
Nektar Therapeutics today announced that new Phase 2 clinical data for NKTR-102, Nektar's lead oncology candidate being evaluated in multiple cancer indications, have been selected for presentation at the 47th Annual Meeting of the American Society of Clinical Oncology being held June 3-7, 2011 in Chicago, Illinois.
How is individualized medicine working? Let us count the ways. That's just what Mayo Clinic Vice President Gianrico Farrugia, M.D., did this morning in his opening keynote at the 4th annual Individualizing Medicine Conference. The core of his talk highlighted five areas in which the knowledge and know-how from the human genome will be most impactful in patient care, not just at Mayo Clinic, but anywhere in the nation and globally.
Tumors are not a uniform mass of cells. Colon cancers bear differentiated-like cells, similar to the functional cells of the intestinal wall, and pluripotent cells-the so-called tumour stem cells.
Researchers in Australia are developing diversionary tactics to fool disease-causing bacteria in the gut. Many bacteria, including those responsible for major gut infections, such as cholera, produce toxins that damage human tissues when they bind to complex sugar receptors displayed on the surface of cells in the host's intestine.
› Verified 8 days ago
Dr. Stanley F Penc, MD PHD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 400 Patroon Creek Blvd, Suite 210, Albany, NY 12206 Phone: 518-459-8106 | |
Dr. Donald Stone Higgins Jr., M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 113 Holland Ave, Neurology Service (127), Albany, NY 12208 Phone: 518-626-6391 Fax: 518-626-6369 | |
Dr. Christopher John Hanowitz, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave, Department Of Emergency Medicine, Albany, NY 12208 Phone: 518-262-3095 | |
Daniel Gabriels, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 75 New Scotland Ave, Albany, NY 12208 Phone: 518-447-9611 | |
Ryan Patrick Bochacki, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 113 Holland Ave, Albany, NY 12208 Phone: 518-626-5991 | |
Dr. Amanda Jane Crosier-riffle, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1303 | |
Robert F. Malerba Ii, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 732 Madison Ave, Albany, NY 12208 Phone: 518-436-0874 |